Patents by Inventor Alfons Soder

Alfons Soder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4762833
    Abstract: 2,4,6-Tris-tertiary-butylamino-1,3,5-triazine of the formula I ##STR1## for the prophylaxis and treatment of epilepsy and anxiety states, and the use for the preparation of a medicament for the prophylaxis and treatment of epilepsy and anxiety states, are described.
    Type: Grant
    Filed: April 3, 1987
    Date of Patent: August 9, 1988
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Alfred Kreutzberger, Alfons Soder, Hermann J. Gerhards
  • Patent number: 4576947
    Abstract: A pharmaceutical composition containing as an essential ingredient a compound of the formula ##STR1## wherein one of the groups R.sub.1, R.sub.2 and R.sub.3 is an .omega.- or (.omega.-1)-hydroxyalkyl group having from 5 to 8 carbon atoms in which the hydroxy group is separated from the xanthine nucleus by at least 2 carbon atoms, radicals R.sub.1 and R.sub.3 which are no hydroxylalkyl group, are hydrogen or methyl and equal or different, and R.sub.2 is said hydroxyalkyl group or methyl, a compound of formula (I) and a pharmaceutical product for treatment of diseases involving insufficiency of cerebral blood flow.
    Type: Grant
    Filed: November 10, 1983
    Date of Patent: March 18, 1986
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Heinz-Joachim Hinze, Alfons Soder, Kurt Popendiker
  • Patent number: 4515795
    Abstract: A pharmaceutical composition containing as an essential ingredient a compound of the formula ##STR1## wherein one of the groups R.sub.1, R.sub.2 and R.sub.3 is an .omega.- or (.omega.-1)-hydroxyalkyl group having from 5 to 8 carbon atoms in which the hydroxy group is separated from the xanthine nucleus by at least 2 carbon atoms, radicals R.sub.1 and R.sub.3 which are no hydroxyalkyl group, are hydrogen or methyl and equal or different, and R.sub.2 is said hydroxyalkyl group or methyl, a compound of formula (I) and a pharmaceutical product for treatment of diseases involving insufficiency of cerebral blood flow.
    Type: Grant
    Filed: March 4, 1977
    Date of Patent: May 7, 1985
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Heinz-Joachim Hinze, Alfons Soder, Kurt Popendiker
  • Patent number: 4374990
    Abstract: A compound having the general formula or an acid addition salt thereof ##STR1## in which formula R.sub.1 is selected from the group consisting of(A) an at least mononuclear heterocyclic group having 4 to 10 carbon atoms in the ring system bound to the group ##STR2## through a carbon atom and containing at least one oxygen, nitrogen or sulphur atom,(B) substitution products of (A) containing at least one substituent selected from the group consisting of halogen, trifluoromethyl, hydroxy, alkoxy of 1 to 3 carbon atoms, unsubstituted amino, amino substituted by up to two alkyl groups each having 1 to 3 carbon atoms and alkyl groups having 1 to 6 carbon atoms,X is oxygen, sulphur or an NH-group,Y is an alkylene group having 1 to 3 carbon atoms in the chain, or an alkylene group having 1 to 3 carbon atoms in the chain substituted by (a) up to 3 alkyl groups each having up to 3 carbon atoms and a total of not more than 8 carbon atoms, or (b) substituted by one or two phenyl groups,R.sub.
    Type: Grant
    Filed: October 26, 1979
    Date of Patent: February 22, 1983
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Rolf-Ortwin Weber, Alfons Soder, Istvan Boksay
  • Patent number: 4312861
    Abstract: Aralkylamines of the formula:R.sup.1 --CH.sub.2 --N(R.sup.3)--R.sup.2whereinR.sup.1 is a phenyl substituted by one of:(I) alkyls,(II) halo and(III) nitro;R.sup.2 is(IV) alkyl having from 4 to 10 carbon atoms, four of which are in one chain,(V) alkyl interrupted by an oxygen atom, i.e. an alkoxyalkyl or ether radical, or(VI) hydroxyalkyl wherein the alkyl is either (IV) or (V) and the hydroxy is the sole substituent;R.sup.3 is a hydrogen atom, alkyl having from 1 to 4 carbon atoms or such alkyl substituted by a dialkylphosphinyl group;a physiologically-compatible acid-addition salt thereof and a pharmaceutical composition containing such compound(s) as active ingredient(s) are valuable in view of the physiological activity, e.g. vasotonic, capillary sealing and antiarrhythmic, of the aralkylamines and their physiologically-compatible acid-addition salts.
    Type: Grant
    Filed: June 13, 1977
    Date of Patent: January 26, 1982
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Istvan Boksay, Alfons Soder, Volkher Bollmann, Rolf-Ortwin Weber
  • Patent number: 4207321
    Abstract: A pharmaceutical composition having as an essential ingredient a compound of the formula ##STR1## wherein one to three of R.sup.1, R.sup.2 and R.sup.3 represent an alkenyl group having from 4 to 8 carbon atoms, the other ones are alkyl having from 1 to 12 carbon atoms, and R.sup.1 may also be hydrogen, the compounds themselves and a process for preparing them.
    Type: Grant
    Filed: October 2, 1978
    Date of Patent: June 10, 1980
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Harald Furrer, Alfons Soder, Jaromir Komarek, Heinz-Joachim Hinze, Gerhard Munch
  • Patent number: 4182624
    Abstract: Benzhydryl-imidazole derivatives having carboxyl functions in the imidazole ring have valuable properties in plant protection and growth regulation in agriculture and horticulture. They are also effective as antimycotis, fungicides and herbicides and can be used for combating plant-pathogenic bacteria.
    Type: Grant
    Filed: July 17, 1978
    Date of Patent: January 8, 1980
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Alfons Soder, Hermann Bieringer, Helmut Burstell, Peter Langeluddeke, Burkhard Sachse
  • Patent number: 4160828
    Abstract: A phosphinyl derivative of formula (I) ##STR1## wherein X is =CH-- or =N--,R.sup.1 is(a) phenyl radical,(b) a quinolyl radical,(c) one of the radicals (a) and (b) being substituted by at least one substituent selected from the group consisting of halogen, trifluoromethyl and 1 to 3 alkyl radicals having in total up to 4 carbon atoms,R.sup.2 is selected from the group consisting of a dialkyl-phosphinylalkyl radical and a dialkyl phosphinyl-hydroxyalkyl radical each of said radicals R.sup.2 having a total of from 3 to 7 carbon atomsAnd acid addition salts thereof, pharmaceutical preparations containing said derivatives.
    Type: Grant
    Filed: February 10, 1978
    Date of Patent: July 10, 1979
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Alfons Soder, Klaus Perrey
  • Patent number: 4115569
    Abstract: A compound having the general formula or an acid addition salt thereof ##STR1## in which formula R.sub.1 is selected from the group consisting ofA. an at least mononuclear heterocyclic group having 4 to 10 carbon atoms in the ring system bound to the group ##STR2## through a carbon atom and containing at least one oxygen, nitrogen or sulphur atom,B. substitution products of (A) containing at least one substituent selected from the group consisting of halogen, trifluoromethyl, hydroxy, alkoxy of 1 to 3 carbon atoms, unsubstituted amino, amino substituted by up to two alkyl groups each having 1 to 3 carbon atoms and alkyl groups having 1 to 6 carbon atoms,X is oxygen, sulphur or an NH-group,Y is an alkylene group having 1 to 3 carbon atoms in the chain, or an alkylene group having 1 to 3 carbon atoms in the chain substituted by (a) up to 3 alkyl groups each having up to 3 carbon atoms and a total of not more than 8 carbon atoms, or (b) substituted by one or two phenyl groups,R.sub.
    Type: Grant
    Filed: August 21, 1975
    Date of Patent: September 19, 1978
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Rolf-Ortwin Weber, Alfons Soder, Istvan Boksay
  • Patent number: 4108995
    Abstract: Compound of the formula ##STR1## wherein one of the groups R.sub.1, R.sub.2 and R.sub.3 is a hydroxyalkyl group containing from 4 to 8 carbon atoms, one of the other two, which may be the same or different, is an alkyl group containing from 2 to 12 carbon atoms and the third one is an alkyl group containing from 1 to 12 carbon atoms or a hydrogen atom, R.sub.2 however being an alkyl or hydroxyalkyl group, at least one of the groups R.sub.1, R.sub.2 and R.sub.3 containing at least 5 carbon atoms, a process for their preparation and a pharmaceutical composition containing said compounds.
    Type: Grant
    Filed: July 5, 1974
    Date of Patent: August 22, 1978
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Werner Mohler, Manfred Jayme, Heinz-Joachim Hinze, Jaromir Komarek, Mario Reiser, Alfons Soder
  • Patent number: 4091095
    Abstract: A phosphinyl derivative of formula ##STR1## wherein X is selected from the group consisting of a carbon atom with a hydrogen atom attached thereto and a nitrogen atom,R.sup.1 isA. a phenyl radical,B. a quinolyl radical,C. one of the radicals (a) and (b) being substituted by at least one substituent selected from the group consisting of halogen, trifluoromethyl and 1 to 3 alkyl radicals having in total up to 4 carbon atoms,R.sup.2 is selected from the group consisting of a dialkylphosphinylalkyl radical and a dialkyl phosphinyl-hydroxyalkyl radical each of said radicals R.sup.2 having a total of from 3 to 7 carbon atomsAnd acid addition salts thereof, pharmaceutical preparations containing said derivatives.
    Type: Grant
    Filed: July 6, 1976
    Date of Patent: May 23, 1978
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Alfons Soder, Klaus Perrey